NEW YORK, July 29, 2019 /PRNewswire/ -- WeissLaw
LLP is investigating possible breaches of fiduciary duty
and other violations of law by the Board of Directors of Mylan N.V.
("Mylan" or the "Company") (NASDAQ: MYL) in connection with the
proposed acquisition of the Company by Pfizer Inc. ("Pfizer")
(NYSE: PFE). Under the terms of the agreement, Mylan
shareholders will own a meager 43% of the combined company.
If you own Mylan shares and wish to discuss
this investigation or have any questions concerning this notice or
your rights or interests, please contact:
Joshua Rubin,
Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Visit our website
http://www.weisslawllp.com/mylan-nv/
Or follow us on Twitter @MarketsAlert
WeissLaw is investigating whether Mylan's Board acted to
maximize shareholder value prior to entering into the acquisition
agreement. Notably, the deal is a strategic transaction from
which Pfizer hopes to leverage Mylan's product portfolio to make
significant gains in the market. According to the acquisition
announcement, "[t]he transaction will allow the new company to
meaningfully expand the geographic reach of Mylan's existing broad
product portfolio and future pipeline – including significant
investments that have been made across complex generics and
biosimilars – into new growth markets."
WeissLaw is investigating whether Mylan's Board conducted a fair
process in agreeing to the proposed acquisition, whether the
proposed acquisition undervalues the Company, and whether all
material information related to the proposed acquisition is fully
and fairly disclosed.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-mylan-nv-300892688.html
SOURCE WeissLaw LLP